Results 91 to 100 of about 61,573 (234)

Penetration of Piperacillin/Tazobactam Into Gynecologic Tissues Following a Single Loading Dose Prior to Hysterectomy [PDF]

open access: yes, 1994
Objective: This study was undertaken to determine plasma and pelvic tissue concentrations of piperacillin/tazobactam following a single intravenous administration.Methods: Plasma and tissue samples were obtained following administration of 3 g of ...
O\u27Brien, William F.   +3 more
core   +1 more source

Mystery and misery of locally‐delivered drug therapy in periodontics. Historical concepts and current state

open access: yesPeriodontology 2000, EarlyView.
Abstract The primary objective is to critically analyze approaches to local therapy for periodontal disease, particularly in light of its well‐established systemic implications. We specifically address common misconceptions and overestimations regarding the potential of local treatments in contrast to their actual clinical effectiveness.
Andrea Mombelli, Alkisti Zekeridou
wiley   +1 more source

Novel and emerging antimicrobial strategies in the management of oral infections

open access: yesPeriodontology 2000, EarlyView.
Abstract Background Antibiotics marked a pivotal turning point in human civilization, enhancing social interactions and extending human life expectancy. In addition to their success in treating systemic infectious diseases, they have significantly improved periodontal treatment outcomes as an adjunct therapy.
Ozge Unlu, Nil Yakar, Alpdogan Kantarci
wiley   +1 more source

An evaluation of piperacillin-tazobactam antimicrobial stewardship intervention and association with β-lactam susceptibility in Pseudomonas aeruginosa and Enterobacter cloacae complex

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
Introduction: Antimicrobial resistance is a growing global concern. At our hospital, susceptibility of Pseudomonas aeruginosa to piperacillin-tazobactam declined from 95% to 77%, while susceptibility of Enterobacter cloacae complex decreased from 82% to ...
Ivayla I. Geneva   +3 more
doaj   +1 more source

Effectiveness of nonsurgical therapy of peri‐implant mucositis: A systematic review

open access: yesPeriodontology 2000, EarlyView.
Abstract Objectives This systematic review intends to respond to the question: “How do clinical parameters change in implants affected by peri‐implant mucositis following different non‐surgical treatment approaches or no treatment in patients monitored for a minimum of six months?” Materials and Methods A search for randomized clinical trials (RCTs) or
Giulia Brunello   +4 more
wiley   +1 more source

Comparison of the

open access: yesJournal of Global Antimicrobial Resistance
Objectives: To provide a descriptive analysis of the in vitro antimicrobial susceptibility testing results for all 39,661 Pseudomonas aeruginosa isolates collected by the ATLAS global surveillance programme data from 2020 to 2024 with a focus on ...
Mark A. Estabrook   +3 more
doaj   +1 more source

Severe hidradenitis suppurativa exacerbation in temporal association with PD‐1 blockade in cutaneous squamous cell carcinoma

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Nadine Larissa Fergen   +4 more
wiley   +1 more source

Challenges of Dengue in Hematological Disease Patients: Descriptive Analysis From the DANGO Registry During the 2023–2024 Outbreak in Argentina

open access: yesTransplant Infectious Disease, EarlyView.
During the 2023–2024 Argentine dengue outbreak, 33 patients with hematological disease showed high complication rates, frequent hospitalization (64%), severe thrombocytopenia (90%), and 6% dengue‐attributable mortality. Transfusion‐associated cases were documented.
Gustavo Adolfo Méndez   +16 more
wiley   +1 more source

Ceftolozane-tazobactam activity against drug-resistant Enterobacteriaceae and Pseudomonas aeruginosa causing healthcare-associated infections in Latin America: report from an antimicrobial surveillance program (2013–2015)

open access: yesBrazilian Journal of Infectious Diseases, 2017
This study evaluated the in vitro activity of ceftolozane-tazobactam and comparator agents tested against Latin American isolates of Enterobacteriaceae and Pseudomonas aeruginosa from patients with health care-associated infections.
Michael A. Pfaller   +5 more
doaj   +1 more source

Prevalence of piperacillin/tazobactam resistance in invasive \(Haemophilus\) \(influenzae\) in Germany

open access: yes
Background Haemophilus influenzae (Hi) is a Gram-negative bacterium that may cause sepsis or meningitis, treatment of which mainly includes β-lactam antibiotics. Since 2019 EUCAST breakpoints for piperacillin/tazobactam have been available.
Claus, Heike   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy